IE882554L - Apparatus for delivery of substances - Google Patents
Apparatus for delivery of substancesInfo
- Publication number
- IE882554L IE882554L IE882554A IE255488A IE882554L IE 882554 L IE882554 L IE 882554L IE 882554 A IE882554 A IE 882554A IE 255488 A IE255488 A IE 255488A IE 882554 L IE882554 L IE 882554L
- Authority
- IE
- Ireland
- Prior art keywords
- hot melt
- pressure sensitive
- melt pressure
- sensitive adhesive
- substance
- Prior art date
Links
- 239000000126 substance Substances 0.000 title claims abstract description 48
- 239000000463 material Substances 0.000 claims abstract description 23
- 238000000034 method Methods 0.000 claims abstract description 20
- 238000009828 non-uniform distribution Methods 0.000 claims abstract description 4
- 238000009827 uniform distribution Methods 0.000 claims abstract description 4
- 239000012943 hotmelt Substances 0.000 claims description 58
- 239000004820 Pressure-sensitive adhesive Substances 0.000 claims description 51
- -1 tackifiers Substances 0.000 claims description 25
- 239000010410 layer Substances 0.000 claims description 23
- 239000000945 filler Substances 0.000 claims description 13
- 239000000203 mixture Substances 0.000 claims description 12
- 229920000642 polymer Polymers 0.000 claims description 12
- 239000011241 protective layer Substances 0.000 claims description 7
- 239000004014 plasticizer Substances 0.000 claims description 6
- 229920002367 Polyisobutene Polymers 0.000 claims description 5
- 229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 claims description 5
- 230000015572 biosynthetic process Effects 0.000 claims description 4
- 229920001610 polycaprolactone Polymers 0.000 claims description 4
- 229920002635 polyurethane Polymers 0.000 claims description 4
- 239000004814 polyurethane Substances 0.000 claims description 4
- VSKJLJHPAFKHBX-UHFFFAOYSA-N 2-methylbuta-1,3-diene;styrene Chemical compound CC(=C)C=C.C=CC1=CC=CC=C1.C=CC1=CC=CC=C1 VSKJLJHPAFKHBX-UHFFFAOYSA-N 0.000 claims description 3
- 239000003814 drug Substances 0.000 claims description 3
- 229920001289 polyvinyl ether Polymers 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 239000002537 cosmetic Substances 0.000 claims description 2
- 238000001125 extrusion Methods 0.000 claims description 2
- 238000000465 moulding Methods 0.000 claims description 2
- 229920000647 polyepoxide Polymers 0.000 claims description 2
- 238000005507 spraying Methods 0.000 claims description 2
- 239000013008 thixotropic agent Substances 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 abstract description 9
- 239000004831 Hot glue Substances 0.000 abstract 4
- 239000011253 protective coating Substances 0.000 abstract 1
- 239000013543 active substance Substances 0.000 description 39
- 239000000853 adhesive Substances 0.000 description 19
- 230000001070 adhesive effect Effects 0.000 description 18
- 229920005989 resin Polymers 0.000 description 18
- 239000011347 resin Substances 0.000 description 18
- RSWGJHLUYNHPMX-ONCXSQPRSA-N abietic acid Chemical compound C([C@@H]12)CC(C(C)C)=CC1=CC[C@@H]1[C@]2(C)CCC[C@@]1(C)C(O)=O RSWGJHLUYNHPMX-ONCXSQPRSA-N 0.000 description 11
- 235000014113 dietary fatty acids Nutrition 0.000 description 10
- 150000002148 esters Chemical class 0.000 description 10
- 239000000194 fatty acid Substances 0.000 description 10
- 229930195729 fatty acid Natural products 0.000 description 10
- 239000002904 solvent Substances 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- 150000004665 fatty acids Chemical class 0.000 description 9
- 239000013032 Hydrocarbon resin Substances 0.000 description 8
- KBAYQFWFCOOCIC-GNVSMLMZSA-N [(1s,4ar,4bs,7s,8ar,10ar)-1,4a-dimethyl-7-propan-2-yl-2,3,4,4b,5,6,7,8,8a,9,10,10a-dodecahydrophenanthren-1-yl]methanol Chemical compound OC[C@@]1(C)CCC[C@]2(C)[C@H]3CC[C@H](C(C)C)C[C@H]3CC[C@H]21 KBAYQFWFCOOCIC-GNVSMLMZSA-N 0.000 description 8
- 229920006270 hydrocarbon resin Polymers 0.000 description 8
- 235000013311 vegetables Nutrition 0.000 description 8
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 6
- 239000000155 melt Substances 0.000 description 5
- 239000002304 perfume Substances 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical class OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- 239000012876 carrier material Substances 0.000 description 3
- 229920000728 polyester Polymers 0.000 description 3
- QGMRQYFBGABWDR-UHFFFAOYSA-N sodium;5-ethyl-5-pentan-2-yl-1,3-diazinane-2,4,6-trione Chemical class [Na+].CCCC(C)C1(CC)C(=O)NC(=O)NC1=O QGMRQYFBGABWDR-UHFFFAOYSA-N 0.000 description 3
- 229940100640 transdermal system Drugs 0.000 description 3
- KWGRBVOPPLSCSI-WPRPVWTQSA-N (-)-ephedrine Chemical compound CN[C@@H](C)[C@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WPRPVWTQSA-N 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 2
- 229930000680 A04AD01 - Scopolamine Natural products 0.000 description 2
- QQRSPHJOOXUALR-UHFFFAOYSA-N Apiole Chemical compound COC1=CC(CC=C)=C(OC)C2=C1OCO2 QQRSPHJOOXUALR-UHFFFAOYSA-N 0.000 description 2
- 239000004593 Epoxy Substances 0.000 description 2
- FWKQNCXZGNBPFD-UHFFFAOYSA-N Guaiazulene Chemical compound CC(C)C1=CC=C(C)C2=CC=C(C)C2=C1 FWKQNCXZGNBPFD-UHFFFAOYSA-N 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- STECJAGHUSJQJN-GAUPFVANSA-N Hyoscine Natural products C1([C@H](CO)C(=O)OC2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-GAUPFVANSA-N 0.000 description 2
- RRHGJUQNOFWUDK-UHFFFAOYSA-N Isoprene Chemical compound CC(=C)C=C RRHGJUQNOFWUDK-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- STECJAGHUSJQJN-UHFFFAOYSA-N N-Methyl-scopolamin Natural products C1C(C2C3O2)N(C)C3CC1OC(=O)C(CO)C1=CC=CC=C1 STECJAGHUSJQJN-UHFFFAOYSA-N 0.000 description 2
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 2
- 239000004952 Polyamide Substances 0.000 description 2
- LOUPRKONTZGTKE-WZBLMQSHSA-N Quinine Chemical compound C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@@H]2[C@H](O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-WZBLMQSHSA-N 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- ZZHLYYDVIOPZBE-UHFFFAOYSA-N Trimeprazine Chemical compound C1=CC=C2N(CC(CN(C)C)C)C3=CC=CC=C3SC2=C1 ZZHLYYDVIOPZBE-UHFFFAOYSA-N 0.000 description 2
- NIJJYAXOARWZEE-UHFFFAOYSA-N Valproic acid Chemical compound CCCC(C(O)=O)CCC NIJJYAXOARWZEE-UHFFFAOYSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- DZBUGLKDJFMEHC-UHFFFAOYSA-N acridine Chemical compound C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 description 2
- 239000012790 adhesive layer Substances 0.000 description 2
- ZOJBYZNEUISWFT-UHFFFAOYSA-N allyl isothiocyanate Chemical compound C=CCN=C=S ZOJBYZNEUISWFT-UHFFFAOYSA-N 0.000 description 2
- HJJPJSXJAXAIPN-UHFFFAOYSA-N arecoline Chemical compound COC(=O)C1=CCCN(C)C1 HJJPJSXJAXAIPN-UHFFFAOYSA-N 0.000 description 2
- CUFNKYGDVFVPHO-UHFFFAOYSA-N azulene Chemical compound C1=CC=CC2=CC=CC2=C1 CUFNKYGDVFVPHO-UHFFFAOYSA-N 0.000 description 2
- OSASVXMJTNOKOY-UHFFFAOYSA-N chlorobutanol Chemical compound CC(C)(O)C(Cl)(Cl)Cl OSASVXMJTNOKOY-UHFFFAOYSA-N 0.000 description 2
- YNNUSGIPVFPVBX-NHCUHLMSSA-N clemastine Chemical compound CN1CCC[C@@H]1CCO[C@@](C)(C=1C=CC(Cl)=CC=1)C1=CC=CC=C1 YNNUSGIPVFPVBX-NHCUHLMSSA-N 0.000 description 2
- 229960002881 clemastine Drugs 0.000 description 2
- OROGSEYTTFOCAN-DNJOTXNNSA-N codeine Chemical compound C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC OROGSEYTTFOCAN-DNJOTXNNSA-N 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 229920001971 elastomer Polymers 0.000 description 2
- 239000005038 ethylene vinyl acetate Substances 0.000 description 2
- 229920006244 ethylene-ethyl acrylate Polymers 0.000 description 2
- OKJPEAGHQZHRQV-UHFFFAOYSA-N iodoform Chemical compound IC(I)I OKJPEAGHQZHRQV-UHFFFAOYSA-N 0.000 description 2
- WFLSCFISQHLEED-UHFFFAOYSA-N isoaminile Chemical compound CN(C)C(C)CC(C(C)C)(C#N)C1=CC=CC=C1 WFLSCFISQHLEED-UHFFFAOYSA-N 0.000 description 2
- 229960004216 isoaminile Drugs 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 150000004702 methyl esters Chemical class 0.000 description 2
- 229920002647 polyamide Polymers 0.000 description 2
- OJCPSBCUMRIPFL-UHFFFAOYSA-N prolintane Chemical compound C1CCCN1C(CCC)CC1=CC=CC=C1 OJCPSBCUMRIPFL-UHFFFAOYSA-N 0.000 description 2
- 239000005060 rubber Substances 0.000 description 2
- STECJAGHUSJQJN-FWXGHANASA-N scopolamine Chemical compound C1([C@@H](CO)C(=O)O[C@H]2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-FWXGHANASA-N 0.000 description 2
- 229960002646 scopolamine Drugs 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 description 1
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 description 1
- FMCGSUUBYTWNDP-ONGXEEELSA-N (1R,2S)-2-(dimethylamino)-1-phenyl-1-propanol Chemical compound CN(C)[C@@H](C)[C@H](O)C1=CC=CC=C1 FMCGSUUBYTWNDP-ONGXEEELSA-N 0.000 description 1
- IGLYMJRIWWIQQE-QUOODJBBSA-N (1S,2R)-2-phenylcyclopropan-1-amine (1R,2S)-2-phenylcyclopropan-1-amine Chemical compound N[C@H]1C[C@@H]1C1=CC=CC=C1.N[C@@H]1C[C@H]1C1=CC=CC=C1 IGLYMJRIWWIQQE-QUOODJBBSA-N 0.000 description 1
- WYDUSKDSKCASEF-LJQANCHMSA-N (1s)-1-cyclohexyl-1-phenyl-3-pyrrolidin-1-ylpropan-1-ol Chemical compound C([C@](O)(C1CCCCC1)C=1C=CC=CC=1)CN1CCCC1 WYDUSKDSKCASEF-LJQANCHMSA-N 0.000 description 1
- CEMAWMOMDPGJMB-CYBMUJFWSA-N (2r)-1-(propan-2-ylamino)-3-(2-prop-2-enoxyphenoxy)propan-2-ol Chemical compound CC(C)NC[C@@H](O)COC1=CC=CC=C1OCC=C CEMAWMOMDPGJMB-CYBMUJFWSA-N 0.000 description 1
- INTCGJHAECYOBW-APWZRJJASA-N (2s,3r)-4-(dimethylamino)-3-methyl-1,2-diphenylbutan-2-ol Chemical compound C([C@](O)([C@@H](CN(C)C)C)C=1C=CC=CC=1)C1=CC=CC=C1 INTCGJHAECYOBW-APWZRJJASA-N 0.000 description 1
- KWTSXDURSIMDCE-QMMMGPOBSA-N (S)-amphetamine Chemical compound C[C@H](N)CC1=CC=CC=C1 KWTSXDURSIMDCE-QMMMGPOBSA-N 0.000 description 1
- RKUNBYITZUJHSG-FXUDXRNXSA-N (S)-atropine Chemical compound C1([C@@H](CO)C(=O)O[C@H]2C[C@H]3CC[C@@H](C2)N3C)=CC=CC=C1 RKUNBYITZUJHSG-FXUDXRNXSA-N 0.000 description 1
- TWBNMYSKRDRHAT-RCWTXCDDSA-N (S)-timolol hemihydrate Chemical compound O.CC(C)(C)NC[C@H](O)COC1=NSN=C1N1CCOCC1.CC(C)(C)NC[C@H](O)COC1=NSN=C1N1CCOCC1 TWBNMYSKRDRHAT-RCWTXCDDSA-N 0.000 description 1
- ZWLMLVIUWRUDBD-BTJKTKAUSA-N (z)-but-2-enedioate;3-(2-methoxy-10h-phenothiazin-10-ium-10-yl)propyl-dimethylazanium Chemical compound OC(=O)\C=C/C(O)=O.C1=CC=C2N(CCCN(C)C)C3=CC(OC)=CC=C3SC2=C1 ZWLMLVIUWRUDBD-BTJKTKAUSA-N 0.000 description 1
- 150000005208 1,4-dihydroxybenzenes Chemical class 0.000 description 1
- JWDYCNIAQWPBHD-UHFFFAOYSA-N 1-(2-methylphenyl)glycerol Chemical compound CC1=CC=CC=C1OCC(O)CO JWDYCNIAQWPBHD-UHFFFAOYSA-N 0.000 description 1
- 239000001074 1-methoxy-4-[(E)-prop-1-enyl]benzene Substances 0.000 description 1
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 1
- XILVEPYQJIOVNB-UHFFFAOYSA-N 2-[3-(trifluoromethyl)anilino]benzoic acid 2-(2-hydroxyethoxy)ethyl ester Chemical compound OCCOCCOC(=O)C1=CC=CC=C1NC1=CC=CC(C(F)(F)F)=C1 XILVEPYQJIOVNB-UHFFFAOYSA-N 0.000 description 1
- IVQOFBKHQCTVQV-UHFFFAOYSA-N 2-hydroxy-2,2-diphenylacetic acid 2-(diethylamino)ethyl ester Chemical compound C=1C=CC=CC=1C(O)(C(=O)OCCN(CC)CC)C1=CC=CC=C1 IVQOFBKHQCTVQV-UHFFFAOYSA-N 0.000 description 1
- MSXVEPNJUHWQHW-UHFFFAOYSA-N 2-methylbutan-2-ol Chemical compound CCC(C)(C)O MSXVEPNJUHWQHW-UHFFFAOYSA-N 0.000 description 1
- IKQUUYYDRTYXAP-UHFFFAOYSA-N 3-methylpenta-1,4-diene Chemical compound C=CC(C)C=C IKQUUYYDRTYXAP-UHFFFAOYSA-N 0.000 description 1
- PFEOZHBOMNWTJB-UHFFFAOYSA-N 3-methylpentane Chemical compound CCC(C)CC PFEOZHBOMNWTJB-UHFFFAOYSA-N 0.000 description 1
- UDKVBVICMUEIKS-UHFFFAOYSA-N 4-[(6-chloro-2-methoxyacridin-9-yl)azaniumyl]pentyl-diethylazanium;dichloride Chemical compound Cl.Cl.C1=C(OC)C=C2C(NC(C)CCCN(CC)CC)=C(C=CC(Cl)=C3)C3=NC2=C1 UDKVBVICMUEIKS-UHFFFAOYSA-N 0.000 description 1
- KFZXVMNBUMVKLN-UHFFFAOYSA-N 4-chloro-5-methyl-2-propan-2-ylphenol Chemical compound CC(C)C1=CC(Cl)=C(C)C=C1O KFZXVMNBUMVKLN-UHFFFAOYSA-N 0.000 description 1
- WFJIVOKAWHGMBH-UHFFFAOYSA-N 4-hexylbenzene-1,3-diol Chemical compound CCCCCCC1=CC=C(O)C=C1O WFJIVOKAWHGMBH-UHFFFAOYSA-N 0.000 description 1
- USSIQXCVUWKGNF-UHFFFAOYSA-N 6-(dimethylamino)-4,4-diphenylheptan-3-one Chemical compound C=1C=CC=CC=1C(CC(C)N(C)C)(C(=O)CC)C1=CC=CC=C1 USSIQXCVUWKGNF-UHFFFAOYSA-N 0.000 description 1
- WNCAVNGLACHSRZ-KAMYIIQDSA-N Allithiamine Chemical compound C=CCSSC(/CCO)=C(/C)N(C=O)CC1=CN=C(C)N=C1N WNCAVNGLACHSRZ-KAMYIIQDSA-N 0.000 description 1
- WNCAVNGLACHSRZ-UHFFFAOYSA-N Allithiamine Natural products C=CCSSC(CCO)=C(C)N(C=O)CC1=CN=C(C)N=C1N WNCAVNGLACHSRZ-UHFFFAOYSA-N 0.000 description 1
- 239000004342 Benzoyl peroxide Substances 0.000 description 1
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 1
- 229930008564 C01BA04 - Sparteine Natural products 0.000 description 1
- 229920004939 Cariflex™ Polymers 0.000 description 1
- GXGJIOMUZAGVEH-UHFFFAOYSA-N Chamazulene Chemical compound CCC1=CC=C(C)C2=CC=C(C)C2=C1 GXGJIOMUZAGVEH-UHFFFAOYSA-N 0.000 description 1
- 235000001258 Cinchona calisaya Nutrition 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- MBYXEBXZARTUSS-QLWBXOBMSA-N Emetamine Natural products O(C)c1c(OC)cc2c(c(C[C@@H]3[C@H](CC)CN4[C@H](c5c(cc(OC)c(OC)c5)CC4)C3)ncc2)c1 MBYXEBXZARTUSS-QLWBXOBMSA-N 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- OGDVEMNWJVYAJL-LEPYJNQMSA-N Ethyl morphine Chemical compound C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OCC OGDVEMNWJVYAJL-LEPYJNQMSA-N 0.000 description 1
- OGDVEMNWJVYAJL-UHFFFAOYSA-N Ethylmorphine Natural products C1C(N(CCC234)C)C2C=CC(O)C3OC2=C4C1=CC=C2OCC OGDVEMNWJVYAJL-UHFFFAOYSA-N 0.000 description 1
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 1
- RKUNBYITZUJHSG-UHFFFAOYSA-N Hyosciamin-hydrochlorid Natural products CN1C(C2)CCC1CC2OC(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-UHFFFAOYSA-N 0.000 description 1
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 1
- PWWVAXIEGOYWEE-UHFFFAOYSA-N Isophenergan Chemical compound C1=CC=C2N(CC(C)N(C)C)C3=CC=CC=C3SC2=C1 PWWVAXIEGOYWEE-UHFFFAOYSA-N 0.000 description 1
- HLFSDGLLUJUHTE-SNVBAGLBSA-N Levamisole Chemical compound C1([C@H]2CN3CCSC3=N2)=CC=CC=C1 HLFSDGLLUJUHTE-SNVBAGLBSA-N 0.000 description 1
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 description 1
- 229920000877 Melamine resin Polymers 0.000 description 1
- AJXPJJZHWIXJCJ-UHFFFAOYSA-N Methsuximide Chemical compound O=C1N(C)C(=O)CC1(C)C1=CC=CC=C1 AJXPJJZHWIXJCJ-UHFFFAOYSA-N 0.000 description 1
- DUGOZIWVEXMGBE-UHFFFAOYSA-N Methylphenidate Chemical compound C=1C=CC=CC=1C(C(=O)OC)C1CCCCN1 DUGOZIWVEXMGBE-UHFFFAOYSA-N 0.000 description 1
- SIDLZWOQUZRBRU-UHFFFAOYSA-N Methyprylon Chemical compound CCC1(CC)C(=O)NCC(C)C1=O SIDLZWOQUZRBRU-UHFFFAOYSA-N 0.000 description 1
- FMCGSUUBYTWNDP-UHFFFAOYSA-N N-Methylephedrine Natural products CN(C)C(C)C(O)C1=CC=CC=C1 FMCGSUUBYTWNDP-UHFFFAOYSA-N 0.000 description 1
- 229920002292 Nylon 6 Polymers 0.000 description 1
- 229920005987 OPPANOL® Polymers 0.000 description 1
- CWRVKFFCRWGWCS-UHFFFAOYSA-N Pentrazole Chemical compound C1CCCCC2=NN=NN21 CWRVKFFCRWGWCS-UHFFFAOYSA-N 0.000 description 1
- WLWFNJKHKGIJNW-UHFFFAOYSA-N Phensuximide Chemical compound O=C1N(C)C(=O)CC1C1=CC=CC=C1 WLWFNJKHKGIJNW-UHFFFAOYSA-N 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 229920000297 Rayon Polymers 0.000 description 1
- AUVVAXYIELKVAI-UHFFFAOYSA-N SJ000285215 Natural products N1CCC2=CC(OC)=C(OC)C=C2C1CC1CC2C3=CC(OC)=C(OC)C=C3CCN2CC1CC AUVVAXYIELKVAI-UHFFFAOYSA-N 0.000 description 1
- 239000002174 Styrene-butadiene Substances 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- KLBQZWRITKRQQV-UHFFFAOYSA-N Thioridazine Chemical compound C12=CC(SC)=CC=C2SC2=CC=CC=C2N1CCC1CCCCN1C KLBQZWRITKRQQV-UHFFFAOYSA-N 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- XSTXAVWGXDQKEL-UHFFFAOYSA-N Trichloroethylene Chemical group ClC=C(Cl)Cl XSTXAVWGXDQKEL-UHFFFAOYSA-N 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- SIVHMKRQTQHNIO-UHFFFAOYSA-N [3-(dimethylamino)-2-hydroxypropyl] 4-(propylamino)benzoate Chemical compound CCCNC1=CC=C(C(=O)OCC(O)CN(C)C)C=C1 SIVHMKRQTQHNIO-UHFFFAOYSA-N 0.000 description 1
- 229960003216 aceclidine Drugs 0.000 description 1
- 150000001241 acetals Chemical class 0.000 description 1
- WRJPSSPFHGNBMG-UHFFFAOYSA-N acetic acid 1-azabicyclo[2.2.2]octan-3-yl ester Chemical compound C1CC2C(OC(=O)C)CN1CC2 WRJPSSPFHGNBMG-UHFFFAOYSA-N 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 230000001171 adenosinetriphosphoric effect Effects 0.000 description 1
- 150000001278 adipic acid derivatives Chemical class 0.000 description 1
- 229960003790 alimemazine Drugs 0.000 description 1
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 description 1
- 235000016720 allyl isothiocyanate Nutrition 0.000 description 1
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- SLRCCWJSBJZJBV-UHFFFAOYSA-N alpha-isosparteine Natural products C1N2CCCCC2C2CN3CCCCC3C1C2 SLRCCWJSBJZJBV-UHFFFAOYSA-N 0.000 description 1
- PAZJSJFMUHDSTF-UHFFFAOYSA-N alprenolol Chemical compound CC(C)NCC(O)COC1=CC=CC=C1CC=C PAZJSJFMUHDSTF-UHFFFAOYSA-N 0.000 description 1
- 229960002213 alprenolol Drugs 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 229940025084 amphetamine Drugs 0.000 description 1
- 229960003116 amyl nitrite Drugs 0.000 description 1
- 229940070436 apiole Drugs 0.000 description 1
- 235000002484 apiole Nutrition 0.000 description 1
- 150000004982 aromatic amines Chemical class 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- SEBMTIQKRHYNIT-UHFFFAOYSA-N azatadine Chemical compound C1CN(C)CCC1=C1C2=NC=CC=C2CCC2=CC=CC=C21 SEBMTIQKRHYNIT-UHFFFAOYSA-N 0.000 description 1
- 229960000383 azatadine Drugs 0.000 description 1
- 229960001498 benactyzine Drugs 0.000 description 1
- KVBYPTUGEKVEIJ-UHFFFAOYSA-N benzene-1,3-diol;formaldehyde Chemical compound O=C.OC1=CC=CC(O)=C1 KVBYPTUGEKVEIJ-UHFFFAOYSA-N 0.000 description 1
- 235000019400 benzoyl peroxide Nutrition 0.000 description 1
- 229960003328 benzoyl peroxide Drugs 0.000 description 1
- 229940036350 bisabolol Drugs 0.000 description 1
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- NTXGQCSETZTARF-UHFFFAOYSA-N buta-1,3-diene;prop-2-enenitrile Chemical compound C=CC=C.C=CC#N NTXGQCSETZTARF-UHFFFAOYSA-N 0.000 description 1
- MTAZNLWOLGHBHU-UHFFFAOYSA-N butadiene-styrene rubber Chemical compound C=CC=C.C=CC1=CC=CC=C1 MTAZNLWOLGHBHU-UHFFFAOYSA-N 0.000 description 1
- VWYQKFLLGRBICZ-UHFFFAOYSA-N butanilicaine Chemical compound CCCCNCC(=O)NC1=C(C)C=CC=C1Cl VWYQKFLLGRBICZ-UHFFFAOYSA-N 0.000 description 1
- 229920005549 butyl rubber Polymers 0.000 description 1
- 229960002504 capsaicin Drugs 0.000 description 1
- YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 229960003609 cathine Drugs 0.000 description 1
- DLNKOYKMWOXYQA-IONNQARKSA-N cathine Chemical compound C[C@H](N)[C@@H](O)C1=CC=CC=C1 DLNKOYKMWOXYQA-IONNQARKSA-N 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 229920006217 cellulose acetate butyrate Polymers 0.000 description 1
- 229920003086 cellulose ether Polymers 0.000 description 1
- PMRJYBALQVLLSJ-UHFFFAOYSA-N chamazulene Natural products CCC1=CC2=C(C)CCC2=CC=C1 PMRJYBALQVLLSJ-UHFFFAOYSA-N 0.000 description 1
- 229910052729 chemical element Inorganic materials 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229960004926 chlorobutanol Drugs 0.000 description 1
- 229940031956 chlorothymol Drugs 0.000 description 1
- ZPEIMTDSQAKGNT-UHFFFAOYSA-N chlorpromazine Chemical compound C1=C(Cl)C=C2N(CCCN(C)C)C3=CC=CC=C3SC2=C1 ZPEIMTDSQAKGNT-UHFFFAOYSA-N 0.000 description 1
- PUFQVTATUTYEAL-UHFFFAOYSA-N cinchocaine Chemical compound C1=CC=CC2=NC(OCCCC)=CC(C(=O)NCCN(CC)CC)=C21 PUFQVTATUTYEAL-UHFFFAOYSA-N 0.000 description 1
- 229960001747 cinchocaine Drugs 0.000 description 1
- LOUPRKONTZGTKE-UHFFFAOYSA-N cinchonine Natural products C1C(C(C2)C=C)CCN2C1C(O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-UHFFFAOYSA-N 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical class OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 1
- 229960004126 codeine Drugs 0.000 description 1
- 229940075614 colloidal silicon dioxide Drugs 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 238000012936 correction and preventive action Methods 0.000 description 1
- 229960004397 cyclophosphamide Drugs 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- KWGRBVOPPLSCSI-UHFFFAOYSA-N d-ephedrine Natural products CNC(C)C(O)C1=CC=CC=C1 KWGRBVOPPLSCSI-UHFFFAOYSA-N 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- OWQIUQKMMPDHQQ-UHFFFAOYSA-N dimethocaine Chemical compound CCN(CC)CC(C)(C)COC(=O)C1=CC=C(N)C=C1 OWQIUQKMMPDHQQ-UHFFFAOYSA-N 0.000 description 1
- 229950010160 dimethocaine Drugs 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- MSYUMPGNGDNTIQ-UHFFFAOYSA-N dixyrazine Chemical compound C12=CC=CC=C2SC2=CC=CC=C2N1CC(C)CN1CCN(CCOCCO)CC1 MSYUMPGNGDNTIQ-UHFFFAOYSA-N 0.000 description 1
- 229960005146 dixyrazine Drugs 0.000 description 1
- DLNKOYKMWOXYQA-UHFFFAOYSA-N dl-pseudophenylpropanolamine Natural products CC(N)C(O)C1=CC=CC=C1 DLNKOYKMWOXYQA-UHFFFAOYSA-N 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- AUVVAXYIELKVAI-CKBKHPSWSA-N emetine Chemical compound N1CCC2=CC(OC)=C(OC)C=C2[C@H]1C[C@H]1C[C@H]2C3=CC(OC)=C(OC)C=C3CCN2C[C@@H]1CC AUVVAXYIELKVAI-CKBKHPSWSA-N 0.000 description 1
- 229960002694 emetine Drugs 0.000 description 1
- AUVVAXYIELKVAI-UWBTVBNJSA-N emetine Natural products N1CCC2=CC(OC)=C(OC)C=C2[C@H]1C[C@H]1C[C@H]2C3=CC(OC)=C(OC)C=C3CCN2C[C@H]1CC AUVVAXYIELKVAI-UWBTVBNJSA-N 0.000 description 1
- SLWGJZPKHAXZQL-UHFFFAOYSA-N emylcamate Chemical compound CCC(C)(CC)OC(N)=O SLWGJZPKHAXZQL-UHFFFAOYSA-N 0.000 description 1
- 229960000650 emylcamate Drugs 0.000 description 1
- JPGQOUSTVILISH-UHFFFAOYSA-N enflurane Chemical compound FC(F)OC(F)(F)C(F)Cl JPGQOUSTVILISH-UHFFFAOYSA-N 0.000 description 1
- 229960000305 enflurane Drugs 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 229960002179 ephedrine Drugs 0.000 description 1
- 150000002118 epoxides Chemical class 0.000 description 1
- UVTJKLLUVOTSOB-UHFFFAOYSA-N etaqualone Chemical compound CCC1=CC=CC=C1N1C(=O)C2=CC=CC=C2N=C1C UVTJKLLUVOTSOB-UHFFFAOYSA-N 0.000 description 1
- 229950010472 etaqualone Drugs 0.000 description 1
- HAPOVYFOVVWLRS-UHFFFAOYSA-N ethosuximide Chemical compound CCC1(C)CC(=O)NC1=O HAPOVYFOVVWLRS-UHFFFAOYSA-N 0.000 description 1
- 229960002767 ethosuximide Drugs 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 239000005042 ethylene-ethyl acrylate Substances 0.000 description 1
- 229960004578 ethylmorphine Drugs 0.000 description 1
- 229960001493 etofenamate Drugs 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 229950010338 fencarbamide Drugs 0.000 description 1
- PJMPHNIQZUBGLI-UHFFFAOYSA-N fentanyl Chemical compound C=1C=CC=CC=1N(C(=O)CC)C(CC1)CCN1CCC1=CC=CC=C1 PJMPHNIQZUBGLI-UHFFFAOYSA-N 0.000 description 1
- 229960002428 fentanyl Drugs 0.000 description 1
- IRYFCWPNDIUQOW-UHFFFAOYSA-N fluanisone Chemical compound COC1=CC=CC=C1N1CCN(CCCC(=O)C=2C=CC(F)=CC=2)CC1 IRYFCWPNDIUQOW-UHFFFAOYSA-N 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229960002350 guaiazulen Drugs 0.000 description 1
- BCQZXOMGPXTTIC-UHFFFAOYSA-N halothane Chemical compound FC(F)(F)C(Cl)Br BCQZXOMGPXTTIC-UHFFFAOYSA-N 0.000 description 1
- 229960003132 halothane Drugs 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- OROGSEYTTFOCAN-UHFFFAOYSA-N hydrocodone Natural products C1C(N(CCC234)C)C2C=CC(O)C3OC2=C4C1=CC=C2OC OROGSEYTTFOCAN-UHFFFAOYSA-N 0.000 description 1
- 229930005342 hyoscyamine Natural products 0.000 description 1
- 229960003210 hyoscyamine Drugs 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 150000002484 inorganic compounds Chemical class 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- MOYKHGMNXAOIAT-JGWLITMVSA-N isosorbide dinitrate Chemical compound [O-][N+](=O)O[C@H]1CO[C@@H]2[C@H](O[N+](=O)[O-])CO[C@@H]21 MOYKHGMNXAOIAT-JGWLITMVSA-N 0.000 description 1
- 229960000201 isosorbide dinitrate Drugs 0.000 description 1
- 229940116298 l- malic acid Drugs 0.000 description 1
- 229960001614 levamisole Drugs 0.000 description 1
- 229960004194 lidocaine Drugs 0.000 description 1
- 239000000395 magnesium oxide Substances 0.000 description 1
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 1
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 229960003861 mephenesin Drugs 0.000 description 1
- 229960003729 mesuximide Drugs 0.000 description 1
- 229960001797 methadone Drugs 0.000 description 1
- 229950008620 methopromazine Drugs 0.000 description 1
- RFKMCNOHBTXSMU-UHFFFAOYSA-N methoxyflurane Chemical compound COC(F)(F)C(Cl)Cl RFKMCNOHBTXSMU-UHFFFAOYSA-N 0.000 description 1
- 229960002455 methoxyflurane Drugs 0.000 description 1
- OJLOPKGSLYJEMD-URPKTTJQSA-N methyl 7-[(1r,2r,3r)-3-hydroxy-2-[(1e)-4-hydroxy-4-methyloct-1-en-1-yl]-5-oxocyclopentyl]heptanoate Chemical compound CCCCC(C)(O)C\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)OC OJLOPKGSLYJEMD-URPKTTJQSA-N 0.000 description 1
- 229960002221 methylephedrine Drugs 0.000 description 1
- 229960002238 methylpentynol Drugs 0.000 description 1
- QXLPXWSKPNOQLE-UHFFFAOYSA-N methylpentynol Chemical compound CCC(C)(O)C#C QXLPXWSKPNOQLE-UHFFFAOYSA-N 0.000 description 1
- 229960001344 methylphenidate Drugs 0.000 description 1
- 229960000316 methyprylon Drugs 0.000 description 1
- MJFJKKXQDNNUJF-UHFFFAOYSA-N metixene Chemical compound C1N(C)CCCC1CC1C2=CC=CC=C2SC2=CC=CC=C21 MJFJKKXQDNNUJF-UHFFFAOYSA-N 0.000 description 1
- 229960005103 metixene Drugs 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 229960005249 misoprostol Drugs 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- CSDTZUBPSYWZDX-UHFFFAOYSA-N n-pentyl nitrite Chemical compound CCCCCON=O CSDTZUBPSYWZDX-UHFFFAOYSA-N 0.000 description 1
- NCYVXEGFNDZQCU-UHFFFAOYSA-N nikethamide Chemical compound CCN(CC)C(=O)C1=CC=CN=C1 NCYVXEGFNDZQCU-UHFFFAOYSA-N 0.000 description 1
- 229960003226 nikethamide Drugs 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- XNOPRXBHLZRZKH-DSZYJQQASA-N oxytocin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@H](N)C(=O)N1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 XNOPRXBHLZRZKH-DSZYJQQASA-N 0.000 description 1
- RUVINXPYWBROJD-UHFFFAOYSA-N para-methoxyphenyl Natural products COC1=CC=C(C=CC)C=C1 RUVINXPYWBROJD-UHFFFAOYSA-N 0.000 description 1
- 229960005152 pentetrazol Drugs 0.000 description 1
- WEYVCQFUGFRXOM-UHFFFAOYSA-N perazine Chemical compound C1CN(C)CCN1CCCN1C2=CC=CC=C2SC2=CC=CC=C21 WEYVCQFUGFRXOM-UHFFFAOYSA-N 0.000 description 1
- 229960002195 perazine Drugs 0.000 description 1
- 229920001568 phenolic resin Polymers 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 229960004227 phensuximide Drugs 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- VYMDGNCVAMGZFE-UHFFFAOYSA-N phenylbutazonum Chemical compound O=C1C(CCCC)C(=O)N(C=2C=CC=CC=2)N1C1=CC=CC=C1 VYMDGNCVAMGZFE-UHFFFAOYSA-N 0.000 description 1
- ULSIYEODSMZIPX-UHFFFAOYSA-N phenylethanolamine Chemical compound NCC(O)C1=CC=CC=C1 ULSIYEODSMZIPX-UHFFFAOYSA-N 0.000 description 1
- 150000003014 phosphoric acid esters Chemical class 0.000 description 1
- 150000003021 phthalic acid derivatives Chemical class 0.000 description 1
- 229960005141 piperazine Drugs 0.000 description 1
- FWWDFDMCZLOXQI-UHFFFAOYSA-N pivhydrazine Chemical compound CC(C)(C)C(=O)NNCC1=CC=CC=C1 FWWDFDMCZLOXQI-UHFFFAOYSA-N 0.000 description 1
- 229950008099 pivhydrazine Drugs 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920001084 poly(chloroprene) Polymers 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 239000004632 polycaprolactone Substances 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000003097 polyterpenes Chemical class 0.000 description 1
- 229920002689 polyvinyl acetate Polymers 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- MFDFERRIHVXMIY-UHFFFAOYSA-N procaine Chemical compound CCN(CC)CCOC(=O)C1=CC=C(N)C=C1 MFDFERRIHVXMIY-UHFFFAOYSA-N 0.000 description 1
- 229960004919 procaine Drugs 0.000 description 1
- 229960005253 procyclidine Drugs 0.000 description 1
- 229960004654 prolintane Drugs 0.000 description 1
- 229960003910 promethazine Drugs 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 229960000948 quinine Drugs 0.000 description 1
- MCJGNVYPOGVAJF-UHFFFAOYSA-N quinolin-8-ol Chemical compound C1=CN=C2C(O)=CC=CC2=C1 MCJGNVYPOGVAJF-UHFFFAOYSA-N 0.000 description 1
- 238000009877 rendering Methods 0.000 description 1
- BZGIPVGCJGXQTA-UHFFFAOYSA-N s-[2-(diethylamino)ethyl] n,n-diphenylcarbamothioate Chemical compound C=1C=CC=CC=1N(C(=O)SCCN(CC)CC)C1=CC=CC=C1 BZGIPVGCJGXQTA-UHFFFAOYSA-N 0.000 description 1
- 150000003902 salicylic acid esters Chemical class 0.000 description 1
- 238000009738 saturating Methods 0.000 description 1
- 150000003377 silicon compounds Chemical class 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 229960001945 sparteine Drugs 0.000 description 1
- SLRCCWJSBJZJBV-AJNGGQMLSA-N sparteine Chemical compound C1N2CCCC[C@H]2[C@@H]2CN3CCCC[C@H]3[C@H]1C2 SLRCCWJSBJZJBV-AJNGGQMLSA-N 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000011115 styrene butadiene Substances 0.000 description 1
- 229920003048 styrene butadiene rubber Polymers 0.000 description 1
- YROXIXLRRCOBKF-UHFFFAOYSA-N sulfonylurea Chemical class OC(=N)N=S(=O)=O YROXIXLRRCOBKF-UHFFFAOYSA-N 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- GKCBAIGFKIBETG-UHFFFAOYSA-N tetracaine Chemical compound CCCCNC1=CC=C(C(=O)OCCN(C)C)C=C1 GKCBAIGFKIBETG-UHFFFAOYSA-N 0.000 description 1
- 229960002372 tetracaine Drugs 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 229920002725 thermoplastic elastomer Polymers 0.000 description 1
- 229960002784 thioridazine Drugs 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- 229960004605 timolol Drugs 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- RUVINXPYWBROJD-ONEGZZNKSA-N trans-anethole Chemical compound COC1=CC=C(\C=C\C)C=C1 RUVINXPYWBROJD-ONEGZZNKSA-N 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 229960003741 tranylcypromine Drugs 0.000 description 1
- UBOXGVDOUJQMTN-UHFFFAOYSA-N trichloroethylene Natural products ClCC(Cl)Cl UBOXGVDOUJQMTN-UHFFFAOYSA-N 0.000 description 1
- 229960002415 trichloroethylene Drugs 0.000 description 1
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical class OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 1
- ZEWQUBUPAILYHI-UHFFFAOYSA-N trifluoperazine Chemical compound C1CN(C)CCN1CCCN1C2=CC(C(F)(F)F)=CC=C2SC2=CC=CC=C21 ZEWQUBUPAILYHI-UHFFFAOYSA-N 0.000 description 1
- 229960002324 trifluoperazine Drugs 0.000 description 1
- IRYJRGCIQBGHIV-UHFFFAOYSA-N trimethadione Chemical compound CN1C(=O)OC(C)(C)C1=O IRYJRGCIQBGHIV-UHFFFAOYSA-N 0.000 description 1
- 229960004453 trimethadione Drugs 0.000 description 1
- ZSCDBOWYZJWBIY-UHFFFAOYSA-N trimipramine Chemical compound C1CC2=CC=CC=C2N(CC(CN(C)C)C)C2=CC=CC=C21 ZSCDBOWYZJWBIY-UHFFFAOYSA-N 0.000 description 1
- 229960002431 trimipramine Drugs 0.000 description 1
- UNXRWKVEANCORM-UHFFFAOYSA-N triphosphoric acid Chemical compound OP(O)(=O)OP(O)(=O)OP(O)(O)=O UNXRWKVEANCORM-UHFFFAOYSA-N 0.000 description 1
- 229940048102 triphosphoric acid Drugs 0.000 description 1
- PRBORDFJHHAISJ-UHFFFAOYSA-N tybamate Chemical compound CCCCNC(=O)OCC(C)(CCC)COC(N)=O PRBORDFJHHAISJ-UHFFFAOYSA-N 0.000 description 1
- 229960002560 tybamate Drugs 0.000 description 1
- 229960000604 valproic acid Drugs 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 1
- 235000005282 vitamin D3 Nutrition 0.000 description 1
- 239000011647 vitamin D3 Substances 0.000 description 1
- 229940021056 vitamin d3 Drugs 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/58—Adhesives
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
- G01N33/521—Single-layer analytical elements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- Dermatology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Materials Engineering (AREA)
- Medicinal Preparation (AREA)
- Adhesives Or Adhesive Processes (AREA)
- Coating Apparatus (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Containers And Plastic Fillers For Packaging (AREA)
- Extrusion Moulding Of Plastics Or The Like (AREA)
- Refuse Collection And Transfer (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Fats And Perfumes (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Lubricants (AREA)
Abstract
phe invention concerns a device for the release of substances made of hot-melt adhesives, with uniform or non-uniform distribution of the substances. The hot-melt adhesive has a processing temperature between 40 and 80 degrees Celsius, preferably between 40 and 60 degrees Celsius, and ideally between 40 and 55 degrees Celsius. Also described is a process for manufacturing the device in which the melted hot melt-adhesive containing the substances to be released is applied continuously or intermittently to a support at a hot-melt adhesive temperature between 40 and 80 degrees Celsius, preferably 40 and 60 degrees Celsius, and ideally 45 and 55 degrees Celsius, and in which, if necessary, a protective coating material is applied.
Description
/" r-j r A -7 Dm -- « mt The invention relates to a device for the release of substances from hot melt pressure sensitive adhesives having a non-uniform or uniform distribution of the substances in the hot melt pressure sensitive adhesives, as well as relating to 5 a method for its manufacture and use thereof.
Typical examples of such devices are active substance containing plasters, indicator systems, devices releasing perfumes and the like, such being frequently used more especially in the medical field for the controlled or 10 uncontrolled release of substances. In such cases, the controlled devices in the form of transdermally controlled systems have acquired special significance. It has also already been disclosed for such systems to apply an active substance containing layer from the melt. A non-adhesive 15 cellulose ether gel, which is applied from the melt and in which active substances may be distributed, has been disclosed in EP-A-0177893. This gel is processed hot and is non-adhesive. A transdermal system is disclosed in DE-OS 32 22 800, wherein active substance, which is packed in 20 microcapsules, is present in a thermally mouldable, adhesive matrix material which is applied from the hot melt.
Articles have been disclosed in US-A-4,515,909, wherein polymers are impregnated with perfume at a high temperature in a solid state. The plastics material there is not molten, but 25 a somewhat softer polymer is impregnated with the perfume at high temperatures.
This method is not suitable for the exact introduction of defined quantities into a polymer.
An attempt has also been made to produce non-adhesive, active substance containing matrices at ambient temperature for temperature-sensitive active substances with a low boiling point or even easy miscibility. For example, it is stated in 5 US-PS 4,379,454 (Campbell et al.) to use an active substance solution for the active substance layer, such solution being brought to a desired viscosity value by means of gelling agents at ambient temperature. From US-PS 4,559,222 (Enscore et al.) it is known to use a mixture, produced at ambient 10 temperature, of mineral oil/polyisobutylene and colloidal silicon dioxide as the viscose layer of active substances for oil-soluble active substances, these layers also being adapted to be adhesive. DE-OS-32 22 800 (Alza) describes a layer of active substance formed from a solution of active substance 15 thickened by means of a rheological agent, such as cellulose, a polysaccharide or a silicon compound, such solution being non-adhesive and being suitable for the rapid release of active substance.
It has been disclosed, from US-PS 3,923,939, to form active 20 substances, such as tetracycline, in a layer of ethylene-vinyl acetate copolymer by hot melt pressing. In EP-A 86 468, an oral antidiabetes sulphonyl urea derivative in a non-adhesive hot melt mass having a melting point of 30 to 90°C is decanted into capsules in predetermined doses from the melt. In US-A-25 3,957,966, it is stated that active substances may be processed in non-adhesive hot melt masses.
It is disclosed, in DE-A-30 07 363, to use an adhesive mixture of a thermoplastic elastomer, here preferably a block polymer of the general formula ABA, an adhesive-rendering resin with 30 oil or higher fatty acids and active substances to produce a simple, transdermal system. The mixture of hot melt pressure sensitive adhesives described there is only suitable for relatively temperature-resistant active substances which tolerate temperatures of 120°C or more.
In US-PS 3,699,963, it is stated that oxytocine may be mixed with adhesives to produce a transdermal therapeutic system and 5 may be deformed at a temperature above 90°C. The transdermal systems thus produced are economical to produce and ensure a constant transfer of active substance by the whole-surface adhesion of the system to the skin.
The prior art methods for producing such systems are not 10 suitable for transdermal systems, which contain temperature-sensitive substances such as scopolamine. In consequence, adhesive layers of active substance were hitherto formed with temperature-sensitive active substances preferably from the solution, and the solvent was evaporated.
The use of solvents in the production of adhesive layers containing active substances is disadvantageous for several reasons. The production of the solutions requires at least one additional, complex method step. It requires high technical outlay and costs for handling the solvents -20 furthermore, for medical reasons, highly pure and hence expensive solvents have to be used in order to ensure a corresponding freedom of residue in the device for the dissolution of the adhesives or their starting materials. An additional problem resides in achieving a freedom from 25 solvents in the device, and expensive drying paths and suction systems are required therefor. Costs additionally occur by recovering or separating the solvents in order to avoid environmental pollution. Besides, an additional risk arises due to the combustibility of most solvents. Furthermore, most 30 organic solvents are harmful for the human organism, so that complex protective measures for the persons engaged in the operation have to be taken. In consequence, an object of the invention is to overcome the above-mentioned disadvantages of such prior art devices and methods.
According to the invention, the object is achieved by a device for the release of substances from hot melt pressure sensitive 5 adhesives having a non-uniform or uniform distribution of the substances in the hot melt pressure sensitive adhesives, wherein a mixture of hot melt pressure sensitive adhesive and substance or a solution of the substance in the hot melt pressure sensitive adhesive is present, the hot melt pressure 10 sensitive adhesive having a processing temperature of between 40 and 80°C, preferably between 40 and 60°C and quite especially preferably between 40 and 55°C.
The operation may thus be carried out at low temperatures without solvents, whereby it is possible to achieve a 15 considerable saving of materials, an accelerated production of the device without the time-consuming drying steps and a production of devices according to the invention which are less harmful to the environment, thereby producing, inter alia, a considerably more economical and also solvent-free 20 product. The device is such that the hot melt pressure sensitive adhesive, having the substance(s) to be released, may be present as one or more layers. The hot melt pressure sensitive adhesive is preferably provided with a carrier, which is permeable or impermeable to the substance(s) to be 25 released.
The hot melt pressure sensitive adhesive may be one, for example, which is produced on the basis of styrene-isoprene-styrene block polymers, polycaprolactones, ethylene-vinylacetate copolymers, polyurethane, polyepoxides, 30 polyisobutene, polyvinyl ethers, optionally with the addition of plasticizers, tackifiers, filler materials, anti-agers and/or thixotropic agents.
A method, according to the invention, of producing a device of the invention comprises continuously or discontinuously applying molten hot melt pressure sensitive adhesive which contains the substance to be released at a temperature of the 5 hot melt pressure sensitive adhesive of between 40 and 80°C, preferably 40 to 60°C and especially preferably 40 to 55°C, to a carrier and optionally applying the protective layer material.
An additional method of the invention comprises continuously 10 or discontinuously applying molten hot melt pressure sensitive adhesive which contains the substance to be released at a temperature of the hot melt pressure sensitive adhesive of between 40 and 80°C, preferably 40 to 60°C and especially preferably 40 and 55°C, to a protective layer material and 15 optionally applying the carrier.
For the use of highly volatile and/or thermally unstable substances to be released, the particular processing measures mentioned hereinafter may be indicated: A. working at as low temperatures as possible; 20 B. increasing the external pressure in order to reduce the evaporation; C. saturating the steam chamber over the hot melt with the vapour-like substance; and D. working with as small a quantity of volatile substance in 25 the melt as possible according to the rules.
These measures, such as, for example, working in an enclosed system, are limited of course by the legal procedures known i to the person skilled in the art because of the intended purpose of the device to be produced and also because of the 30 facts governing the substances.
The devices according to the invention, more especially the transdermal systems, may be used, for example, for the local or systematic processing of active substances in human or animal medicine or in cosmetics, preferably for the release 5 of temperature-sensitive and/or highly volatile substances.
What is understood here by the term hot melt pressure sensitive adhesive is any pressure sensitive adhesive which is sufficiently fluid when hot in order to be applied easily at a temperature above substantially 40°C.
The hot melt pressure sensitive adhesives which are utilisable according to the invention may include, inter alia, those which are commonly known to the person skilled in the art and are derivable from, inter alia, DE-A-15 94 268 (Sun Oil Co.), DE-A-24 13 979 (E.I. Du Pont De Nemours), DE-A-24 35 863 (Dynamit Nobel AG); DE-A-28 00 302 (Ciba-Geigy); EP-A-104 005 (Personal Products Co), JP 61 042 583 and JP 61 281 810, EP-A-131 460 (Exxon) and EP-A-234 856 (Exxon), EP-A-185 992 (Eastman Kodak) as well as from US-PS 3,699,963 and US-PS 4,358,557 (Eastman Kodak), reference being expressly made to this prior art in order to avoid repetition.
In such cases, examples of basic polymers which may be used are polyamides, polyesters, polycaprolactames, polycaprolactones, ethylene-vinyl acetate copolymers (EVA), ethylene-ethyl acrylate copolymers (EEA), polyvinyl ethers, 25 polyacrylate esters, polyvinyl acetals, polyvinylacetates, styrene-butadiene block polymers, isoprene block polymers, polyurethanes, ethyl cellulose, cellulose acetate butyrate, synthesis rubbers (e.g. neoprene rubber), polyisobutylene, butyl rubber, acrylonitrile butadiene mixed polymers, epoxy 30 resins, melamine resins, phenol formaldehyde resins and resorcin formaldehyde resins, and the following modifying resins may also be used, inter alia: hydrated colophonium, polymerised colophonium, dimerised resin acids, disproportionated colophonium, methyl esters of colophonium, glycerine esters of hydrated colophonium, methyl esters of hydrated colophonium, pental esters, triethylene glycol esters of hydrated colophonium, hydroabiethyl alcohol and its 5 derivatives, glycerine esters, di-triol esters and pentaesters of resin acids, pental esters of polymerised colophonium, # pental esters of dimerised colophonium, glycerine esters of dimerised colophonium, esters of maleic acid or phenol-modified colophonium, aromatic and aliphatic hydrocarbon 10 resins, hydrated resins, polyterpene resins, modified terpene resins, waxes, low-molecular polyethylene and polypropylene, or alkyl-styrene copolymers. To these resins may optionally be added plasticizers, such as, for example, adipic acid esters, phosphoric acid esters, phthalic acid esters, 15 polyesters, fatty acid esters, citric acid esters or epoxy plasticizers. Furthermore, stabilizers, such as tocopherol, substituted phenols, hydroquinones, pyrocatechines, aromatic amines and optionally also filler materials, such as, for example, titanium dioxide, magnesium oxide, zinc oxide and 20 silicon dioxide, may also be admixed.
The formation of the components of the device, which have hot melt pressure sensitive adhesives with a processing temperature of between 40 and 80°C, may be effected by extrusion, moulding, roller application, knife application, 25 spraying or by a printing process.
A limit value for the processability of the hot melt pressure sensitive adhesives in many of these methods is given with a viscosity in the region of substantially 80000 Pa s.
If the base which is to be treated with the adhesive - such 30 base being a component of the device - might be damaged by the temperature of the adhesive which is applied hot - either by decomposition, reaction or partial melting - a cooled base may be used. The cooling may be effected by methods known per se, such as by introducing cold, inert gases or bringing into contact with a cooling surface.
The hot melt pressure sensitive adhesive may be applied to the protective layer or the cover material in layer form, for 5 example, or in individual regions according to a predetermined pattern.
Depending on the intended use - if, for example, the substance to be released is to be released through the rear layer, as may be in the case, for example, of essential oils, such as 10 perfumes - the hot melt pressure sensitive adhesive may be provided with a carrier which is permeable to the substance(s) to be released, while a rear layer, which is impermeable to the substance to be released, is preferred for the embodiment of the device as a transdermal system, wherein the substance 15 is only to be released to the skin.
Because of the method according to the invention, the use of adhesive materials containing solvents may now be avoided when processing temperature-sensitive and highly volatile substances, and such results in a considerable increase in the 20 reliability of the production, since no toxic solvent residues remain in fact in the medical form, a considerably simplified method of application produced and a considerable saving in manufacturing costs. In such case, the method may also of course be used advantageously for substances which are 25 scarcely temperature-sensitive, since considerable costs can also be saved thereby.
What is understood by the term "substances" in connection with the present invention are chemical elements, organic and inorganic compounds, which may migrate from the components 30 containing them of such a device and thereby cause a sought-after effect. Among the fields of application of the device according to the invention, human and animal medicine is of particular significance, whereby one embodiment of the invention is particularly preferred here in plaster form.
Typical substances which can be processed by devices manufactured according to the invention are: aceclidine, 5 amphetaminile, amphetamine, amyl nitrite, apophedrine, atebrine, alprostadile, azulene, arecoline, anethol, amylene hydrate, acetyl choline, acridine, adenosine triphosphoric acid, L-malic acid, alimemazine, allithiamine, allyl isothiocyanate, aminoethanol, apyzine, apiole, azatadine, 10 alprenolol, ethinazone, benzoyl peroxide, benzyl alcohol, bisabolol, bisnorephedrine, butacetoluide, benactyzine, campher, colecalciferol, chloroalhydrate, clemastine, chlorobutanol, capsaicine, cyclopentamide, clotubinol, chamazulene, dimethocaine, codeine, chloropromazine, quinine, 15 chlorothymol, cyclophosphamide, cinchocaine, chloroambuzile, chlorophenesine, diethyl ethane, divinyl ethane, dexchloropheniramine, dioprostone, dixyrazine, ephedrine, ethosuximide, enallyl propylmal, emyl camate, erytrol tetranitrate, emetine, enflurane, eucalypotol, etofenamate, 20 ethylmorphine, fentanyl, fluanison, guaiazulene, halothane, hyoscyamine, histamine, fencarbamide, hydroxycaine, hexyl resorcin, isoaminile citrate, isosorbide dinitrate, ibuprofene, iodine, iodoform, isoaminile, lidocaine, lopirine, levamisol, methadone, methyprylone, methyl phenidate, 25 mephenesine, methylephedrine, meclastine, methopromazine, mesuximide, nicethamide, norpseudoephedrine, menthol, methoxy flurane, methyl pentynol, metixene, misoprostol, oxytetracaine, oxyprenolol, oxyphene butazone, oxychinoline, pinene, prolintane, procyclidine, piperazine, pivazide, 30 phensuximide, procaine, phenindaraine, promethazine, pentetrazol, profene amine, perazine, resochine, scopolamine, salicylic acid ester, sparteine, trichloroethylene, timolol, trifluoperazine, tetracaine, trimipramine, tranyl cypromine, trimethadione, tybamate, thymol, thioridazine, valproic acid, 35 verapamile, as well as additional active substances, which are familiar to the person skilled in the art and are absorbable via the skin, including mucous membranes. This list of course is not conclusive.
Typical compositions for hot melt pressure sensitive adhesives 5 to be used are those which are produced from between 10 and 80% by wt., preferably 20 to 80% by wt. and especially preferably 20 to 50% by wt., polymer, between 10 and 80% by wt., preferably between 15 to 60% by wt., plasticizer, between 1 and 80% by wt., preferably 15 to 60% by wt. tackifier, 10 optionally 0.1 to 5% by wt. anti-ager and optionally 0 to 70% by wt. filler materials, the sum of the percentages of the components always being 100.
It is preferred that the hot melt pressure sensitive adhesive has 10 to 50% by wt. styrene-isoprene-styrene synthesis 15 rubber, as is commercially obtainable, for example, under the name CARIFLEX TR 1107 belonging to SHELL; between 10 and 80% by wt. of a hydrated alcohol, such as is obtainable, for example, under the name ABITOL belonging to HERCULES; between 10 and 80% by wt. of a hydrocarbon resin, e.g. the HERCURES C 20 resin belonging to HERCULES; between 1 and 40% by wt. of esters of vegetable fatty acids, e.g. MIGLYOL 812 belonging to DYNAMIT NOBEL; and optionally up to 5% by wt. anti-ager, such as hydroquinone, etc., as well as up to 70% by wt. filler materials.
In an alternative, preferred embodiment of the invention, the hot melt pressure sensitive adhesive has 10 to 50% by wt. of a polycaprolactone, e.g. CAPA 650 belonging to INTEROX; between 10 and 80% by wt. of a hydrated alcohol, e.g. ABITOL belonging to HERCULES; between 10 and 80% by wt. of a 30 hydrocarbon resin, e.g. HERCURES C belonging to HERCULES; between 1 and 40% by wt. of esters of vegetable fatty acids, e.g. MIGLYOL 812 belonging to DYNAMIT NOBEL; and optionally up to 5% by wt. anti-ager, as well as up to 70% by wt. filler materials.
It may also be preferred that the hot melt pressure sensitive adhesive has 10 to 50% by wt. polyethylene vinylacetate, such 5 as EVATANE 28-25 belonging to ATOCHEM, between 10 and 80% by wt. of a hydrated alcohol, e.g. ABITOL belonging to HERCULES, between 10 and 80% by wt. of, a hydrocarbon resin, e.g. the HERCURES C resin belonging to HERCULES, between 1 and 40% by wt. of esters of vegetable fatty acids, e.g. MIGLYOL 812 10 belonging to DYNAMIT NOBEL, and optionally up to 5% by wt. anti-ager, such as hydroquinone, etc., as well as up to 70% by wt. filler materials.
A suitable hot melt pressure sensitive adhesive may have 10 to 50% by wt. polyurethane, such as, e.g. LUPHEN P 1110 belonging 15 to BASF, between 10 and 80% by wt. of a hydrated alcohol, e.g. ABITOL belonging to HERCULES, between 10 and 80% by wt. of a hydrocarbon resin, e.g. the HERCURES C resin belonging to HERCULES; between 1 and 40% by wt. of esters of vegetable fatty acids, e.g. MIGLYOL 812 belonging to DYNAMIT NOBEL, and 20 optionally up to 5% by wt. anti-ager, as well as up to 70% by wt. filler materials.
It is also possible for the hot melt pressure sensitive adhesive to have 10 to 50% by wt. polyamide, such as, for example, EURELON 930 belonging to SCHERING, between 10 and 80% 25 by wt. of a hydrated alcohol, for example, ABITOL belonging to HERCULES, between 10 and 80% by wt. of a hydrocarbon resin, for example, the HERCURES C resin belonging to HERCULES; between 1 and 40% by wt. of esters of vegetable fatty acids, for example, MIGLYOL 812 belonging to DYNAMIT NOBEL, and 30 optionally up to 5% by wt. anti-ager, as well as up to 70% by wt. filler materials.
A hot melt pressure sensitive adhesive may also be used with 10 to 50% by wt. epoxide, such as, for example, EUREPOX 7001 belonging to SCHERING, between 10 and 80% by wt. of a hydrated alcohol, for example, ABITOL belonging to HERCULES, between 5 10 and 80% by wt. of a hydrocarbon resin, for example, the HERCURES C resin belonging to HERCULES, between 1 and 40% by wt. of esters of vegetable fatty acids, for example, MIGLYOL 812 belonging to DYNAMIT NOBEL, and optionally up to 5% by wt. anti-ager, such as hydroquinone, etc., as well as up to 70% by 10 wt. filler materials.
An additional hot melt pressure sensitive adhesive, which can be used for producing transdermal systems of the invention, has 10 to 50% by wt. polyisobutene with a viscous-adhesive, rubber-like consistency, such as, for example, OPPANOL B 50 15 belonging to BASF, between 10 and 80% by wt. of a hydrated alcohol, e.g. ABITOL belonging to HERCULES, between 10 and 80% by wt. of a hydrocarbon resin, for example the HERCURES C resin belonging to HERCULES; between 1 and 40% by wt. of esters of vegetable fatty acids, e.g. MIGLYOL 812 belonging to 20 DYNAMIT NOBEL, and optionally up to 5% by wt. anti-ager, as well as up to 70% by wt. filler materials.
Finally, it is preferred to use hot melt pressure sensitive adhesives, which are based on polyester and have, for example, between 10 to 80% by wt. of a hydrated alcohol, for example 25 ABITOL belonging to HERCULES, between 10 and 80% by wt. of a hydrocarbon resin, e.g. the HERCURES C resin belonging to HERCULES; between 1 and 40% by wt. of esters of vegetable fatty acids, for example, MIGLYOL 812 belonging to DYNAMIT NOBEL, and optionally up to 5% by wt. anti-ager, as well as 30 up to 70% by wt. filler materials.
Furthermore, devices according to the invention may also have one or more substance deposits, in which the substance is present with a concentration higher than the active substance containing layer of hot melt pressure sensitive adhesive, whereby higher doses of the substance may be processed and, in consequence, the device may remain longer in operation before it has to be changed. Typical embodiments are found, for 5 example, in DE-OS 36 29 304.0. Preferred embodiments of the invention are mentioned in the sub-claims, to which reference is expressly made hereby.
Additional features and advantages of the invention are explained hereinafter with reference to the accompanying 10 drawing. In the drawings Fig. 1 is a schematically illustrated cross-sectional view through the layers of a device according to the invention with a substance deposit; Fig. 2 is a schematically illustrated cross-sectional 15 view through an alternative device according to the invention with an active substance deposit; and Fig. 3 is a schematically illustrated cross-sectional view through an alternative embodiment of a device according to the invention without a substance deposit.
Fig. 1 illustrates a device according to the invention, which is here in the form of a plaster-like, active substance containing, transdermal, therapeutic system. It has a layer 12 of hot melt pressure sensitive adhesive, a deposit 14 of active substance, in which the active substance has at least a higher concentration than in the layer 12 of hot melt pressure sensitive adhesive, as well as an active substance impermeable carrier 10, on which the deposit 14 of active substance rests, and is adhered to the skin 18. Active substance now travels continuously at a predetermined rate through the skin 18, whereby the active substance content in the layer 12 decreases. The reduction in active substance is compensated for by active substance flowing subsequently from the deposit 14 of active substance, so that an equilibrium concentration of the active substance in the layer 12 of hot melt pressure sensitive adhesive prevails over a 5 predeterminable period of time, such concentration ensuring the release of a constant quantity of active substance to the skin 18.
Fig. 2 illustrates an alternative embodiment of a device according to the invention, wherein a deposit 14 of active 10 substance is surrounded on all sides by the layer 12 of hot melt pressure sensitive adhesive. This embodiment is especially suitable when a large area of contact between the deposit of active substance and the layer of hot melt pressure sensitive adhesive is desired for a rapid release of active 15 substance to the layer of hot melt pressure sensitive adhesive.
Fig. 3 illustrates an alternative, simple embodiment of a device according to the invention, wherein an active substance containing layer 12 of hot melt pressure sensitive adhesive is 20 applied to an impermeable carrier material 10 in such a manner that the carrier material 10 covers the layer 12 on three sides. It is adhered to the skin by the free surface of hot melt pressure sensitive adhesive, so that a whole-surface contact is ensured over the application period, and the 25 transition of the active substance to the skin is always effected over a constant area at a constant rate.
The production, which has been improved by the invention, of a device according to the invention is described hereinafter.
A mixture of the components of the hot melt pressure sensitive 30 adhesive and the substance to be processed is initially produced. This mixture is brought to processing temperature and then applied to a carrier material from the melt. Further processing, such as applying an adhesive protective layer material, is effected in the usual manner.
List of reference numerals. carrier 12 layer of hot melt pressure sensitive adhesive 14 deposit for the substance to be released 18 skin *
Claims (13)
1. Device for the release of substances from hot melt pressure sensitive adhesives having a non-uniform or uniform distribution of the substances in the hot melt 5 pressure sensitive adhesives, characterised in that a mixture of hot melt pressure sensitive adhesive and substance or a solution of the substance in the hot melt pressure sensitive adhesive is present, the hot melt pressure sensitive adhesive having a processing 10 temperature of between 40 and 80°C, preferably between 40 and 60°C and especially preferably between 40 and 55°C.
2. Devices according to claim 1, characterised in that the hot melt pressure sensitive adhesive, having the substance(s) to be released, is present as one or more 15 layers.
3. Device according to one of claims 1 or 2, characterised in that the hot melt pressure sensitive adhesive is provided with a carrier, which is permeable or impermeable to the substance(s) to be released. 20
4. Device according to one of the preceding claims, characterised in that the hot melt pressure sensitive adhesive is produced on the basis of styrene-isoprene-styrene block polymers, polycaprolactones, ethylene-vinylacetate copolymers, polyurethane, polyepoxides, 25 polyisobutene, polyvinyl ethers, optionally with the addition of plasticizers, tackifiers, filler materials, anti-agers, and/or thixotropic agents.
5. Device according to claim 4, characterised in that the hot melt pressure sensitive adhesive is produced from 30 between 10 and 80% by wt., preferably 20 to 80% by wt. and especially preferably 20 to 50% by wt., polymer, - 18 - between 1 and 80% by wt., preferably 1 to 60% by wt., plasticizer, between 10 and 80% by wt., preferably 15 to 60% by wt., tackifier, optionally 0.1 to 5% by wt. anti-agers and optionally 0 to 70% by wt. filler materials, the sum of the percentages of the components always being 100.
6. Device according to one of the preceding claims characterised in that it has a removable protective layer.
7. Method of producing a device according to one of the preceding claims, characterised by continuously or discontinuously applying a molten mixture of hot melt pressure sensitive adhesive and substance to be released at a temperature of the mixture of between 40 and 80°C, preferably 40 to 60°C and especially preferably 45 and 55°C, to a carrier and optionally applying a protective layer material.
8. Method of producing a device according to one of claims 1 to 6, characterised by continuously or discontinuously applying a molten mixture of hot melt pressure sensitive adhesive and substance to be released at a temperature of the mixture of between 40 and 80°C, preferably 40 to 60°C and especially preferably 45 and 55°C, to a protective layer material and optionally applying the carrier.
9. Method of producing a device according to one of claims 7 or 8, characterised in that the formation of the components of the device, which have hot melt pressure sensitive adhesives with a processing temperature of between 40 and 80°C, is effected by extrusion, moulding, roller application, knife application, spraying or by a printing process. - 19 -
10. Use of the device according one of claims 1 to 6 in the field of human and veterinary medicine, diagnostics or cosmetics.
11. Use of the device according to claim 10 for the release 5 of temperature-sensitive and/or highly volatile substance.
12. A device substantially as hereinbefore described with reference to the drawings.
13. A method of producing a device substantially as 10 hereinbefore described with reference to the drawings. Dated this 22nd day of August 1988 CRUICKSHANK & CO. Agents for the Applicants 1 Holies Street 15 Dublin 2
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE3729165 | 1987-09-01 | ||
DE19873743945 DE3743945A1 (en) | 1987-09-01 | 1987-12-23 | DEVICE FOR DELIVERING SUBSTANCES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE |
Publications (2)
Publication Number | Publication Date |
---|---|
IE882554L true IE882554L (en) | 1989-03-01 |
IE62943B1 IE62943B1 (en) | 1995-03-08 |
Family
ID=25859260
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IE255488A IE62943B1 (en) | 1987-09-01 | 1988-08-22 | Apparatus for the delivery of substances process for the production thereof and use thereof |
Country Status (23)
Country | Link |
---|---|
EP (1) | EP0305756B1 (en) |
JP (1) | JP2781579B2 (en) |
KR (1) | KR970006448B1 (en) |
AT (1) | ATE83655T1 (en) |
AU (1) | AU636835B2 (en) |
CA (1) | CA1333688C (en) |
CZ (1) | CZ281743B6 (en) |
DE (2) | DE3743945A1 (en) |
DK (1) | DK175442B1 (en) |
ES (1) | ES2036242T3 (en) |
FI (1) | FI96577C (en) |
GR (1) | GR3006666T3 (en) |
HU (1) | HU205268B (en) |
IE (1) | IE62943B1 (en) |
IL (1) | IL87538A (en) |
MY (1) | MY103757A (en) |
NO (1) | NO178684C (en) |
NZ (1) | NZ225918A (en) |
PL (1) | PL163710B1 (en) |
PT (1) | PT88378B (en) |
SK (1) | SK279300B6 (en) |
WO (1) | WO1989001787A1 (en) |
YU (1) | YU47201B (en) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3743946A1 (en) * | 1987-09-01 | 1989-03-09 | Lohmann Gmbh & Co Kg | DEVICE FOR DELIVERING NITROGLYCERIN TO THE SKIN, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE |
HU203285B (en) * | 1988-02-01 | 1991-07-29 | Egyt Gyogyszervegyeszeti Gyar | Method for producing transdermal preparation containing vegetable extract |
JP2758002B2 (en) * | 1988-09-14 | 1998-05-25 | 積水化学工業株式会社 | Patch |
DE3843238C1 (en) * | 1988-12-22 | 1990-02-22 | Lohmann Therapie Syst Lts | |
DE3843237A1 (en) * | 1988-12-22 | 1990-07-05 | Lohmann Therapie Syst Lts | TRANSDERMAL THERAPEUTIC SYSTEM WITH AN ANTIADIPOSITUM AS AN ACTIVE INGREDIENT |
DE3843239C1 (en) * | 1988-12-22 | 1990-02-22 | Lohmann Therapie Syst Lts | |
DE4031881C2 (en) * | 1990-10-08 | 1994-02-24 | Sanol Arznei Schwarz Gmbh | Solvent-free, oral sustained-release pharmaceutical preparation and process for its preparation |
DE4237252C2 (en) | 1992-11-04 | 1994-10-13 | Zweckform Buero Prod Gmbh | Flexible, removable, residue-free removable fabric, process for its production and its use |
DE4301781C2 (en) * | 1993-01-23 | 1995-07-20 | Lohmann Therapie Syst Lts | Patch containing nitroglycerin, process for its production and use |
DE4332094C2 (en) * | 1993-09-22 | 1995-09-07 | Lohmann Therapie Syst Lts | Active substance plaster which can be produced without solvent and process for its preparation |
US5380760A (en) * | 1993-11-19 | 1995-01-10 | Minnesota Mining And Manufacturing Company | Transdermal prostaglandin composition |
DE4403487C2 (en) * | 1994-02-04 | 2003-10-16 | Lohmann Therapie Syst Lts | Pharmaceutical patches with UV-crosslinkable acrylate copolymers |
DE19650471A1 (en) * | 1996-12-05 | 1998-06-10 | Beiersdorf Ag | Patches containing active ingredient |
DE19700913C2 (en) * | 1997-01-14 | 2001-01-04 | Lohmann Therapie Syst Lts | Transdermal therapeutic system for the delivery of hormones |
DE19825499C2 (en) | 1998-06-08 | 2003-07-17 | Beiersdorf Ag | Patches containing active ingredients |
DE19834496B4 (en) * | 1998-07-31 | 2004-02-26 | Beiersdorf Ag | Improved release of ibuprofen from hotmelt adhesives in plasters containing active ingredients by adding pharmaceutical auxiliaries and using auxiliaries to improve the release of ibuprofen |
DE19911262C2 (en) * | 1999-03-13 | 2003-04-10 | Scs Skin Care Systems Gmbh | Device for dispensing cosmetic active ingredients |
FR2810238B1 (en) | 2000-06-15 | 2002-07-19 | Oreal | FILM-FORMING COSMETIC COMPOSITION |
FR2810239B1 (en) * | 2000-06-15 | 2002-12-20 | Oreal | FILM-FORMING COSMETIC COMPOSITION |
FR2810237B1 (en) * | 2000-06-15 | 2002-07-26 | Oreal | FILM-FORMING COSMETIC COMPOSITION |
DE10041478A1 (en) | 2000-08-24 | 2002-03-14 | Sanol Arznei Schwarz Gmbh | New pharmaceutical composition |
DE10056009A1 (en) * | 2000-11-11 | 2002-05-16 | Beiersdorf Ag | Well tolerated plaster for controlled delivery of hyperemic agents, having active agent-containing matrix comprising polyisobutylene, amorphous poly-alpha-olefin and filler |
DE10118282A1 (en) | 2001-04-12 | 2002-12-05 | Lohmann Therapie Syst Lts | Pressure sensitive adhesive based on ethylene-vinyl acetate copolymers and adhesive resins, for medical purposes |
WO2003061613A1 (en) | 2002-01-24 | 2003-07-31 | L'oreal | Composition containing a semi-crystalline polymer and an ester |
DE10234673B4 (en) * | 2002-07-30 | 2007-08-16 | Schwarz Pharma Ag | Hot-melt TTS for the administration of rotigotine and process for its preparation, and use of rotigotine in the manufacture of a hot-melt TTS |
DE10236319A1 (en) * | 2002-08-08 | 2004-02-19 | Beiersdorf Ag | Active agent containing matrix plaster for the controlled delivery of an active agent to the skin comprises a pharmaceutical active agent containing a water insoluble adhesive matrix comprising a styrene block copolymer |
JP2004277345A (en) * | 2003-03-17 | 2004-10-07 | Daikyo Yakuhin Kogyo Kk | Plaster and method for producing the same |
DE10312062A1 (en) * | 2003-03-18 | 2004-09-30 | Tesa Ag | Low-shrinkage hotmelt pressure sensitive adhesive, process for its production and use |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3923939A (en) * | 1974-06-07 | 1975-12-02 | Alza Corp | Process for improving release kinetics of a monolithic drug delivery device |
JPS55141408A (en) * | 1979-04-19 | 1980-11-05 | Hisamitsu Pharmaceut Co Inc | Novel plaster containing steroid and its production |
US4725272A (en) * | 1981-06-29 | 1988-02-16 | Alza Corporation | Novel bandage for administering beneficial drug |
GB2118040A (en) * | 1982-02-15 | 1983-10-26 | Hoechst Uk Ltd | Oral anti-diabetic preparation |
JPS58141225A (en) * | 1982-02-16 | 1983-08-22 | Takasago Corp | Resin composition for fragrant material |
CA1239318A (en) * | 1983-04-27 | 1988-07-19 | Hans R. Hoffmann | Pharmaceutical product preferably in medical bandage form and process for producing them |
US4564364A (en) * | 1983-05-26 | 1986-01-14 | Alza Corporation | Active agent dispenser |
ATE95430T1 (en) * | 1984-12-22 | 1993-10-15 | Sanol Arznei Schwarz Gmbh | ACTIVE PATCHES. |
DE3629304A1 (en) * | 1986-08-28 | 1988-03-24 | Lohmann Gmbh & Co Kg | TRANSDERMAL THERAPEUTIC SYSTEM, ITS USE AND METHOD FOR THE PRODUCTION THEREOF |
JPH0816053B2 (en) * | 1986-12-04 | 1996-02-21 | 大正製薬株式会社 | Method of manufacturing patch |
DE3743946A1 (en) * | 1987-09-01 | 1989-03-09 | Lohmann Gmbh & Co Kg | DEVICE FOR DELIVERING NITROGLYCERIN TO THE SKIN, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE |
-
1987
- 1987-12-23 DE DE19873743945 patent/DE3743945A1/en active Granted
-
1988
- 1988-08-03 DE DE8888112630T patent/DE3876898D1/en not_active Expired - Lifetime
- 1988-08-03 WO PCT/DE1988/000477 patent/WO1989001787A1/en active IP Right Grant
- 1988-08-03 KR KR1019890700772A patent/KR970006448B1/en not_active Expired - Fee Related
- 1988-08-03 HU HU884702A patent/HU205268B/en not_active IP Right Cessation
- 1988-08-03 ES ES198888112630T patent/ES2036242T3/en not_active Expired - Lifetime
- 1988-08-03 EP EP88112630A patent/EP0305756B1/en not_active Expired - Lifetime
- 1988-08-03 JP JP63506544A patent/JP2781579B2/en not_active Expired - Lifetime
- 1988-08-03 AU AU22506/88A patent/AU636835B2/en not_active Ceased
- 1988-08-03 AT AT88112630T patent/ATE83655T1/en not_active IP Right Cessation
- 1988-08-10 MY MYPI88000912A patent/MY103757A/en unknown
- 1988-08-19 CA CA000575201A patent/CA1333688C/en not_active Expired - Lifetime
- 1988-08-22 IE IE255488A patent/IE62943B1/en not_active IP Right Cessation
- 1988-08-23 IL IL8753888A patent/IL87538A/en not_active IP Right Cessation
- 1988-08-24 NZ NZ225918A patent/NZ225918A/en unknown
- 1988-08-31 CZ CS885873A patent/CZ281743B6/en not_active IP Right Cessation
- 1988-08-31 PT PT88378A patent/PT88378B/en not_active IP Right Cessation
- 1988-08-31 SK SK5873-88A patent/SK279300B6/en unknown
- 1988-09-01 PL PL88274486A patent/PL163710B1/en unknown
- 1988-09-01 YU YU166288A patent/YU47201B/en unknown
-
1989
- 1989-04-12 NO NO891507A patent/NO178684C/en unknown
- 1989-04-28 DK DK198902102A patent/DK175442B1/en not_active IP Right Cessation
- 1989-04-28 FI FI892053A patent/FI96577C/en not_active IP Right Cessation
-
1992
- 1992-12-24 GR GR920403040T patent/GR3006666T3/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IE882554L (en) | Apparatus for delivery of substances | |
US5273757A (en) | Apparatus for the delivery of substances, processes for the production thereof and use thereof | |
US5126144A (en) | Apparatus delivering nitroglycerin to the skin, process for the production thereof and use thereof | |
US5411739A (en) | Apparatus for the controlled delivery of nicotine, process for the production thereof and use thereof | |
AU707963B2 (en) | Estradiol penetration enhancers | |
US4732892A (en) | L-α-amino acids as transdermal penetration enhancers | |
JPH07138153A (en) | Percutaneous supply of effective medicine | |
US5306502A (en) | Apparatus for delivering nitroglycerin to the skin, processes for the production thereof and the use thereof | |
HRP920857A2 (en) | Apparatus for the delivery of substances process for the production and use thereof | |
HRP920832A2 (en) | Device for the release of nitro-glycirine on the skin, methods of manufacture and use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK9A | Patent expired |